Lupus Science & Medicine
is a global, peer reviewed, Open Access online journal that provides a central point for publication of basic, clinical,
translational, and epidemiological studies of all aspects of lupus and related diseases. It is the first lupus-specific Open
Access journal in the world and has been developed in response to the need for a barrier-free forum for publication of groundbreaking
studies in lupus.
An official journal of the Lupus Foundation of America (LFA), which is dedicated to advancing the science and medicine of lupus while offering support to patients and their caregivers.
Lupus Science & Medicine articles are now discoverable via PubMed and PubMed Central.
We know that authors can find the manuscript submission process time-consuming, so we have implemented a streamlined submission process for original research articles. By asking fewer questions at initial submission we hope to minimise the time that authors spend uploading their manuscripts and responding to post-submission queries, resulting in a faster time to first decision.
The Lupus Science & Medicine blog features interviews with key opinion leaders conducted by the journal's Social Media Editor, Ioannis Parodis. Prof. Richard Furie talks about the results from a phase II trial of anifrolumab, a type I IFN receptor antagonist.
Read the latest news from the Lupus Foundation of America and visit their website for more information